SAGE Articles, Sage Therapeutics Inc. - From 04/17/24

Wednesday, Sage Therapeutics Inc (NASDAQ:SAGE) announced topline results from the PRECEDENT Phase 2 study of dalzanemdor (SAGE-718) in pe...

U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Wednesday. Shares of J B Hunt Transport Services Inc ...

Sage Therapeutics, Inc. (NASDAQ: SAGE) reported better-than-expected fourth-quarter revenue results on Wednesday. Sage Therapeutics posted a quart...

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2...

NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigat...

NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Por...

SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Sage Therapeutics, Inc. (NASDAQ:SAGE) investors who suffered substantial lo...